CLINICAL_TRIALS
trial_result
· 2020-12-04
Clinical Trial Update: Safety and Efficacy of tocilizuMAb Versus Placebo in Polymyalgia rHeumatica With glucocORticoid dEpendence SEMAPHORE [Phase 3]
Summary
Phase 3 trial assessing safety and efficacy of tocilizumab versus placebo in glucocorticoid-dependent polymyalgia rheumatica has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University Hospital, Brest | Conditions: Polymyalgia Rheumatica | Phase 3 | Status: COMPLETED